OPTIBIOTIX HLTH PLC LS-02

Research OPTIBIOTIX HLTH PLC LS-02 (OB3) on Bullrun: market cap EUR 7.02M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOB3
• ExchangeF
• CountryUnited Kingdom
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 7.02M
• Financial periodFY2024
• RevenueEUR 870.00K
• Revenue growth35.1%
• Net income-EUR 1.81M
• Free cash flow-EUR 1.77M
• Gross margin38.0%

Valuation Snapshot

latest market cap is EUR 7.02M.

About OPTIBIOTIX HLTH PLC LS-02

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits.

Frequently asked questions

What is OPTIBIOTIX HLTH PLC LS-02's market cap?

OPTIBIOTIX HLTH PLC LS-02's market capitalization is EUR 7.02M.

What does OPTIBIOTIX HLTH PLC LS-02 do?

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.